Armata Pharmaceuticals, Inc. — Director's Dealing 2017

Jan 31, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2017-01-30

Reporting Person: BILINSKY IGOR (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-30	Stock Option (Right to Buy)	$0.46	A	247322	Acquired	2027-01-29	Common Stock (247322)	Direct

Footnotes

F1: 1/4th of the shares subject to the option vest on January 30, 2018. The remainder of the shares vest in equal monthly installments thereafter over the next three years.